This brand name is authorized in Nigeria.
The drug BABADOL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
QTG126297Q - DICLOFENAC SODIUM
|
|
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
|
2
|
UNII
362O9ITL9D - ACETAMINOPHEN
|
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-9094 | Tablet | Babadol Tablets TAB 50 mg; 325 mg 10 x 1 x 10's (in blisters) | Uncoated Tablet 30 CMS-PP-403092 BABADOL TABLETS PARACETAMOL BP 325MG AND DICLOFENAC SODIUM BP 50MG EACH TABLET CONTAINS PARACETAMOL BP 325MG AND DICLOFENAC SODIUM BP 50MG EXCIPIENTS Excipients MAIZE STARCH, METHYL PARABEN, PROPYL PARABEN, TALCUM, SODIUM STARCH GLYCOLATE, MAGNESSIUM STEARTE, COLLODIAL SILICON DIOXIDE B4-9094 Drugs Imported Products 110 Prescription Only Medicine (POM) 1/29/2024 PATRICKLINGO PHARMACEUTICALS LIMITED, 107, Upper Iweka Road, Onitsha, Anambra State, Nigeria. 8033443825 patricklingopharma@gmail.com WINTECH PHARMACEUTICALS., PLOT NO. 45-46, STICE, MUSALGAON, SINNAR 422112, DIST. NASHIK, MAHARASHTRA, INDIA, India | 28/02/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M01AB55 | Diclofenac, combinations | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-9094 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.